Scarica l'app Stockscreener
1.31
1.50%
-0.02
Dopo l'orario di chiusura:
1.30
-0.01
-0.76%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PACB Giù?
Forum
Previsione
Precedente Chiudi:
$1.33
Aprire:
$1.34
Volume 24 ore:
3.26M
Relative Volume:
0.38
Capitalizzazione di mercato:
$393.49M
Reddito:
$188.87M
Utile/perdita netta:
$-400.38M
Rapporto P/E:
-0.8733
EPS:
-1.5
Flusso di cassa netto:
$-260.90M
1 W Prestazione:
-5.07%
1M Prestazione:
-14.94%
6M Prestazione:
-10.27%
1 anno Prestazione:
-3.68%
Intervallo 1D:
$1.30
$1.35
Intervallo di 1 settimana:
$1.29
$1.38
Portata 52W:
$0.8511
$2.72
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
Nome
Pacific Biosciences Of California Inc
Settore
Industria
Telefono
650-521-8000
Indirizzo
1305 O'BRIEN DRIVE, MENLO PARK, CA
Confronta PACB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
1.31 | 399.49M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
132.66 | 228.64B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.50 | 156.70B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
391.41 | 148.97B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.81 | 117.96B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.34 | 47.69B | 5.69B | 1.41B | 577.90M | 6.95 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-11 | Downgrade | UBS | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-22 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-04-18 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-14 | Iniziato | Guggenheim | Neutral |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-11-17 | Aggiornamento | UBS | Neutral → Buy |
| 2023-10-31 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-06-30 | Iniziato | Goldman | Buy |
| 2023-05-10 | Iniziato | Barclays | Equal Weight |
| 2023-03-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2023-01-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-21 | Ripresa | Cantor Fitzgerald | Overweight |
| 2022-01-06 | Ripresa | Piper Sandler | Neutral |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-09-27 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-02 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-03-09 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-10-15 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | Iniziato | Cowen | Outperform |
| 2017-11-03 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | Downgrade | CL King | Buy → Neutral |
| 2016-11-03 | Reiterato | Cantor Fitzgerald | Buy |
| 2016-06-27 | Iniziato | CL King | Buy |
| 2016-04-15 | Iniziato | First Analysis Sec | Overweight |
| 2016-02-04 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | Reiterato | Cantor Fitzgerald | Buy |
| 2015-10-23 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-02-04 | Reiterato | Maxim Group | Buy |
| 2013-09-26 | Reiterato | Maxim Group | Buy |
| 2013-01-14 | Reiterato | Maxim Group | Buy |
Mostra tutto
Pacific Biosciences Of California Inc Borsa (PACB) Ultime notizie
What makes Pacific Biosciences of California Inc. stock price move sharplyPrice Action & Real-Time Volume Trigger Notifications - Newser
Is Pacific Biosciences of California Inc. stock bottoming outWeekly Investment Recap & Stock Timing and Entry Methods - Newser
Relative strength of Pacific Biosciences of California Inc. in sector analysisTrade Ideas & Risk Controlled Swing Trade Alerts - Newser
Will Pacific Biosciences of California Inc. benefit from macro trendsStop Loss & Weekly High Return Opportunities - Newser
Can momentum traders help lift Pacific Biosciences of California Inc.Day Trade & Weekly Market Pulse Updates - Newser
Real time pattern detection on Pacific Biosciences of California Inc. stockQuarterly Market Summary & Risk Managed Investment Strategies - Newser
What high frequency data says about Pacific Biosciences of California Inc.2025 Big Picture & Scalable Portfolio Growth Methods - Newser
Tick level data insight on Pacific Biosciences of California Inc. volatilityEarnings Overview Summary & AI Powered Buy/Sell Recommendations - Newser
Visual analytics tools that track Pacific Biosciences of California Inc. performanceJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - Newser
Using Ichimoku Cloud for Pacific Biosciences of California Inc. technicals2025 Earnings Impact & Reliable Breakout Stock Forecasts - Newser
Volatility clustering patterns for Pacific Biosciences of California Inc.Market Activity Summary & Daily Stock Momentum Reports - Newser
Will a bounce in Pacific Biosciences of California Inc. offer an exitEarnings Miss & AI Forecast Swing Trade Picks - Newser
Is Pacific Biosciences of California Inc. reversing from oversold territoryMarket Trend Report & Reliable Price Breakout Alerts - Newser
Is Pacific Biosciences of California Inc. affected by consumer sentimentJuly 2025 Drop Watch & AI Powered Buy and Sell Recommendations - sundaytimes.kr
Published on: 2025-08-28 22:15:20 - Newser
Combining machine learning predictions for Pacific Biosciences of California Inc.Market Growth Report & Reliable Price Action Trade Plans - Newser
Should you hold or exit Pacific Biosciences of California Inc. nowMarket Movement Recap & Verified Technical Signals - Newser
Pacific Biosciences Of California Inc Azioni (PACB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):